{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:57:27Z","timestamp":1763499447152,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Project and National 13th Five-Year Science and Technology Project","award":["2016YFD0501302"],"award-info":[{"award-number":["2016YFD0501302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12917-019-1783-2","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:03:23Z","timestamp":1549281803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Susceptibility breakpoint for Danofloxacin against swine Escherichia coli"],"prefix":"10.1186","volume":"15","author":[{"given":"Yuqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishfaq","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruimeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-8105","authenticated-orcid":false,"given":"Xiuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2217\/fmb-2016-0101","volume":"12","author":"C Roussel","year":"2017","unstructured":"Roussel C, Sivignon A, de Wiele TV, Blanquet-Diot S. Foodborne enterotoxigenic Escherichia coli: from gut pathogenesis to new preventive strategies involving probiotics. Future Microbiol. 2017;12:73\u201393.","journal-title":"Future Microbiol"},{"issue":"9888","key":"1783_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209\u201322.","journal-title":"Lancet"},{"issue":"3","key":"1783_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","volume":"18","author":"F Qadri","year":"2005","unstructured":"Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18(3):465\u201383.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1783_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1079\/AHR2005105","volume":"6","author":"JM Fairbrother","year":"2005","unstructured":"Fairbrother JM, Nadeau E, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev. 2005;6(1):17\u201339.","journal-title":"Anim Health Res Rev"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.foodchem.2016.11.029","volume":"221","author":"D Terrado-Campos","year":"2017","unstructured":"Terrado-Campos D, Tayeb-Cherif K, Peris-Vicente J, Carda-Broch S, Esteve-Romero J. Determination of oxolinic acid, danofloxacin, ciprofloxacin, and enrofloxacin in porcine and bovine meat by micellar liquid chromatography with fluorescence detection. Food Chem. 2017;221:1277\u201384.","journal-title":"Food Chem"},{"issue":"2","key":"1783_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1090-0233(02)00258-7","volume":"165","author":"FS Aliabadi","year":"2003","unstructured":"Aliabadi FS, Ali BH, Landoni MF, Lees P. Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids. Vet J. 2003;165(2):104\u201318.","journal-title":"Vet J"},{"issue":"3","key":"1783_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijantimicag.2015.12.019","volume":"47","author":"W Ouyang","year":"2016","unstructured":"Ouyang W, Xue H, Chen Y, Gao W, Li X, Wei J, Wen Z. Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China. Int J Antimicrob Agents. 2016;47(3):210\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"1783_CR8","unstructured":"CDC. CDC (2014). Best practices for comprehensive tobacco control programs Retrieved from CDC Web site: https:\/\/www.cdc.gov\/ecoli\/etec.html . Accessed 26 Jan 2019."},{"issue":"3","key":"1783_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jvp.12482","volume":"41","author":"DGS Burch","year":"2018","unstructured":"Burch DGS, Sperling D. Amoxicillin-current use in swine medicine. J Vet Pharmacol Ther. 2018;41(3):356\u201368.","journal-title":"J Vet Pharmacol Ther"},{"issue":"8","key":"1783_CR10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11259-009-9320-6","volume":"33","author":"C Wang","year":"2009","unstructured":"Wang C, Ai D, Chen C, Lin H, Li J, Shen H, Yi W, Qi Y, Wu H, Cao J. Preparation and evaluation of danofloxacin mesylate microspheres and its pharmacokinetics in pigs. Vet Res Commun. 2009;33(8):1013\u201322.","journal-title":"Vet Res Commun"},{"issue":"4","key":"1783_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/CMR.00002-11","volume":"24","author":"BM Marshall","year":"2011","unstructured":"Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24(4):718\u201333.","journal-title":"Clin Microbiol Rev"},{"key":"1783_CR12","unstructured":"WHO. Antimicrobial resistance: global report on surveillance: World Health Organization; 2014."},{"issue":"12","key":"1783_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/fpd.2011.0868","volume":"8","author":"LN Xia","year":"2011","unstructured":"Xia LN, Tao XQ, Shen JZ, Dai L, Wang Y, Chen X, Wu CM. A survey of beta-lactamase and 16S rRNA methylase genes among fluoroquinolone-resistant Escherichia coli isolates and their horizontal transmission in Shandong, China. Foodborne Pathog Dis. 2011;8(12):1241\u20138.","journal-title":"Foodborne Pathog Dis"},{"issue":"5","key":"1783_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/JCM.02416-16","volume":"55","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Ghannoum MA, Alexander BD. Establishment and use of epidemiological cutoff values for molds and yeasts by use of the clinical and laboratory standards institute M57 standard. J Clin Microbiol. 2017;55(5):1262\u20138.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1783_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/AAC.02456-15","volume":"60","author":"A Espinel-Ingroff","year":"2016","unstructured":"Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, et al. International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother. 2016;60(2):1079\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"1783_CR16","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing: Clinical and Laboratory Standards Institute; 2017."},{"issue":"5","key":"1783_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","volume":"12","author":"J Turnidge","year":"2006","unstructured":"Turnidge J, Kahlmeter G, Kronvall G. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin Microbiol Infect. 2006;12(5):418\u201325.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"1783_CR18","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1128\/JCM.01101-10","volume":"48","author":"G Kronvall","year":"2010","unstructured":"Kronvall G. Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints. J Clin Microbiol. 2010;48(12):4445\u201352.","journal-title":"J Clin Microbiol"},{"key":"1783_CR19","first-page":"385","volume":"7","author":"P Zhang","year":"2016","unstructured":"Zhang P, Hao H, Li J, Ahmad I, Cheng G, Chen D, Tao Y, Huang L, Wang Y, Dai M, et al. The epidemiologic and Pharmacodynamic cutoff values of Tilmicosin against Haemophilus parasuis. Front Microbiol. 2016;7:385.","journal-title":"Front Microbiol"},{"issue":"3","key":"1783_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/jac\/dkm536","volume":"61","author":"CR Frei","year":"2008","unstructured":"Frei CR, Wiederhold NP, Burgess DS. Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. J Antimicrob Chemother. 2008;61(3):621\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1783_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cll.2004.03.009","volume":"24","author":"D Andes","year":"2004","unstructured":"Andes D, Anon J, Jacobs MR, Craig WA. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clin Lab Med. 2004;24(2):477\u2013502.","journal-title":"Clin Lab Med"},{"issue":"Suppl 9A","key":"1783_CR22","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/S0002-9343(01)01026-9","volume":"111","author":"DP Nicolau","year":"2001","unstructured":"Nicolau DP, Ambrose PG. Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae. Am J Med. 2001;111(Suppl 9A):13S\u20138S discussion 36S\u201338S.","journal-title":"Am J Med"},{"issue":"12","key":"1783_CR23","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2460\/ajvr.2001.62.1979","volume":"62","author":"FS Aliabadi","year":"2001","unstructured":"Aliabadi FS, Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. Am J Vet Res. 2001;62(12):1979\u201389.","journal-title":"Am J Vet Res"},{"issue":"4","key":"1783_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2007.12.010","volume":"31","author":"A Fabrega","year":"2008","unstructured":"Fabrega A, Sanchez-Cespedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents. 2008;31(4):307\u201315.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1783_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2307\/1591556","volume":"36","author":"DL Raemdonck","year":"1992","unstructured":"Raemdonck DL, Tanner AC, Tolling ST, Michener SL. In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials. Avian Dis. 1992;36(4):964\u20137.","journal-title":"Avian Dis"},{"issue":"3","key":"1783_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/CMR.00047-06","volume":"20","author":"J Turnidge","year":"2007","unstructured":"Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev. 2007;20(3):391\u2013408 table of contents.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1783_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1128\/AAC.01256-09","volume":"54","author":"MC Arendrup","year":"2010","unstructured":"Arendrup MC, Garcia-Effron G, Lass-Florl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother. 2010;54(1):426\u201339.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1783_CR28","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1128\/AAC.00156-08","volume":"52","author":"JL Rodriguez-Tudela","year":"2008","unstructured":"Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother. 2008;52(7):2468\u201372.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1783_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","volume":"47","author":"FS Aliabadi","year":"2003","unstructured":"Aliabadi FS, Landoni MF, Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrob Agents Chemother. 2003;47(2):626\u201335.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1783_CR30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2460\/ajvr.1993.54.07.1122","volume":"54","author":"C Friis","year":"1993","unstructured":"Friis C. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves. Am J Vet Res. 1993;54(7):1122\u20137.","journal-title":"Am J Vet Res"},{"issue":"6","key":"1783_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2460\/ajvr.1992.53.06.1022","volume":"53","author":"DD Mann","year":"1992","unstructured":"Mann DD, Frame GM. Pharmacokinetic study of danofloxacin in cattle and swine. Am J Vet Res. 1992;53(6):1022\u20136.","journal-title":"Am J Vet Res"},{"issue":"1","key":"1783_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2885.2010.01223.x","volume":"34","author":"Z Zeng","year":"2011","unstructured":"Zeng Z, Deng G, Shen X, Rizwan-Ul-Haq M, Zeng D, Ding H. Plasma and tissue pharmacokinetics of danofloxacin in healthy and in experimentally infected chickens with Pasteurella multocida. J Vet Pharmacol Ther. 2011;34(1):101\u20134.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"1783_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/bcpt.12147","volume":"114","author":"LA Rottboll","year":"2014","unstructured":"Rottboll LA, Friis C. Microdialysis as a tool for drug quantification in the bronchioles of anaesthetized pigs. Basic Clin Pharmacol Toxicol. 2014;114(3):226\u201332.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"1783_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310 quiz 11-12.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1783_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/AAC.31.7.1054","volume":"31","author":"J Blaser","year":"1987","unstructured":"Blaser J, Stone BB, Groner MC, Zinner SH. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987;31(7):1054\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1783_CR36","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1128\/JCM.01096-13","volume":"51","author":"H Hao","year":"2013","unstructured":"Hao H, Pan H, Ahmad I, Cheng G, Wang Y, Dai M, Tao Y, Chen D, Peng D, Liu Z, et al. Susceptibility breakpoint for enrofloxacin against swine Salmonella spp. J Clin Microbiol. 2013;51(9):3070\u20132.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1783_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2885.2011.01338.x","volume":"35","author":"KM Messenger","year":"2012","unstructured":"Messenger KM, Papich MG, Blikslager AT. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs. J Vet Pharmacol Ther. 2012;35(5):452\u20139.","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"1783_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2885.2009.01123.x","volume":"33","author":"M Bimazubute","year":"2010","unstructured":"Bimazubute M, Cambier C, Baert K, Vanbelle S, Chiap P, Albert A, Delporte JP, Gustin P. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther. 2010;33(2):183\u20138.","journal-title":"J Vet Pharmacol Ther"},{"issue":"8","key":"1783_CR39","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1128\/AEM.69.8.4942-4950.2003","volume":"69","author":"S Seurinck","year":"2003","unstructured":"Seurinck S, Verstraete W, Siciliano SD. Use of 16S-23S rRNA intergenic spacer region PCR and repetitive extragenic palindromic PCR analyses of Escherichia coli isolates to identify nonpoint fecal sources. Appl Environ Microbiol. 2003;69(8):4942\u201350.","journal-title":"Appl Environ Microbiol"},{"key":"1783_CR40","volume-title":"CLSI document M07-A9","author":"CLSI","year":"2012","unstructured":"CLSI. CLSI document M07-A9. Wayne: Clinical and Laboratory Standards Institute; 2012."},{"issue":"2","key":"1783_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jac\/dkg312","volume":"52","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Osterlund A, Rodloff A, Steinbakk M, Urbaskova P, Vatopoulos A. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother. 2003;52(2):145\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1783_CR42","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1128\/AAC.05959-11","volume":"56","author":"J Meletiadis","year":"2012","unstructured":"Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob Agents Chemother. 2012;56(5):2524\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1783_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N","volume":"14","author":"MA Garcia","year":"2000","unstructured":"Garcia MA, Solans C, Aramayona JJ, Rueda S, Bregante MA. Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomed Chromatogr. 2000;14(2):89\u201392.","journal-title":"Biomed Chromatogr"},{"issue":"4","key":"1783_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjp.0706974","volume":"150","author":"JA Schrickx","year":"2007","unstructured":"Schrickx JA, Fink-Gremmels J. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br J Pharmacol. 2007;150(4):463\u20139.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1783_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF01062109","volume":"6","author":"K Yamaoka","year":"1978","unstructured":"Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978;6(6):547\u201358.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"5","key":"1783_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","volume":"55","author":"JW Mouton","year":"2005","unstructured":"Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother. 2005;55(5):601\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1783_CR47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1369-5274(00)00132-6","volume":"3","author":"MN Dudley","year":"2000","unstructured":"Dudley MN, Ambrose PG. Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time. Curr Opin Microbiol. 2000;3(5):515\u201321.","journal-title":"Curr Opin Microbiol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-1783-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T14:38:24Z","timestamp":1720967904000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-1783-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-1783-2","relation":{},"ISSN":["1746-6148"],"issn-type":[{"type":"electronic","value":"1746-6148"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental work was performed in accordance with the animal ethics guidelines approved by the animal care and ethics committee of Northeast Agricultural University (Heilongjiang Province PR China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}